Imeik Technology Development Co.,Ltd. Share Price
Equities
300896
CNE100004868
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.10 CNY | +0.31% |
|
+1.02% | +0.27% |
| 01-09 | Imeik Technology Development Gets Approval for Botox Injection; Shares Up 3% | MT |
| 11-14 | Imeik Technology Development Co.,Ltd. Announces Directorate Appointments | CI |
| Capitalization | 42.83B 6.21B 5.44B 4.91B 4.7B 8.52B 575B 8.88B 58.83B 23.26B 275B 23.31B 22.81B 991B | P/E ratio 2025 * |
28.2x | P/E ratio 2026 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise value | 40.79B 5.91B 5.18B 4.68B 4.47B 8.11B 547B 8.45B 56.02B 22.15B 262B 22.19B 21.72B 943B | EV / Sales 2025 * |
15.9x | EV / Sales 2026 * | 13.5x |
| Free-Float |
36.86% | Yield 2025 * |
2.28% | Yield 2026 * | 2.5% |
| 1 day | +0.31% | ||
| 1 week | +1.02% | ||
| Current month | -0.48% | ||
| 1 month | -2.16% | ||
| 3 months | +1.90% | ||
| 6 months | -27.09% | ||
| Current year | +0.27% |
| 1 week | 138 |  | 144.75 |
| 1 month | 137.47 | | 146.79 |
| Current year | 137.45 | | 158.8 |
| 1 year | 137.36 | | 206.66 |
| 3 years | 132.81 | | 425.06 |
| 5 years | 132.81 | | 603.17 |
| 10 years | 123.41 | | 603.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Feng Shi
CEO | Chief Executive Officer | 52 | 31/12/2010 |
Ren Chao Zhang
DFI | Director of Finance/CFO | 48 | 31/10/2021 |
Yong Jian
SEC | Corporate Secretary | 58 | 23/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Jian
CHM | Chairman | 63 | 31/12/2010 |
Yi Feng Shi
BRD | Director/Board Member | 52 | 31/12/2010 |
Lan Zhu Wang
BRD | Director/Board Member | 62 | 31/12/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | +1.02% | -28.95% | -63.39% | 6.21B | |
| -0.13% | -7.62% | -8.87% | +23.35% | 129B | |
| +0.60% | -2.84% | +14.08% | +4.22% | 14.04B | |
| -0.79% | -9.94% | -5.06% | +101.41% | 5.63B | |
| +1.01% | -0.90% | +36.58% | +15.21% | 2.65B | |
| +0.52% | -1.17% | -12.87% | -22.99% | 2.03B | |
| -2.82% | -0.12% | +15.01% | -17.28% | 1.88B | |
| +0.64% | -6.94% | -63.85% | -75.78% | 1.68B | |
| +0.63% | -9.65% | +261.82% | +252.99% | 1.32B | |
| Average | -0.00% | -2.92% | +23.10% | +24.19% | 18.26B | |
| Weighted average by Cap. | -0.06% | -6.54% | -4.96% | +20.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.56B 372M 326M 294M 281M 510M 34.37B 531M 3.52B 1.39B 16.44B 1.39B 1.36B 59.28B | 2.97B 431M 377M 341M 326M 591M 39.85B 616M 4.08B 1.61B 19.07B 1.62B 1.58B 68.73B |
| Net income | 1.52B 221M 193M 174M 167M 302M 20.4B 315M 2.09B 826M 9.76B 828M 810M 35.18B | 1.78B 259M 227M 205M 196M 355M 23.93B 370M 2.45B 969M 11.45B 971M 950M 41.27B |
| Net Debt | -2.05B -297M -260M -235M -225M -407M -27.46B -424M -2.81B -1.11B -13.14B -1.11B -1.09B -47.36B | -2.72B -394M -345M -312M -298M -540M -36.44B -563M -3.73B -1.48B -17.43B -1.48B -1.45B -62.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 142.10 ¥ | +0.31% | 1,865,398 |
| 12/03/26 | 141.66 ¥ | -1.41% | 2,121,926 |
| 11/03/26 | 143.68 ¥ | +2.23% | 3,708,648 |
| 10/03/26 | 140.54 ¥ | +1.31% | 1,809,378 |
| 09/03/26 | 138.72 ¥ | -1.38% | 1,974,401 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300896 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition